The antibiotics concerned are lomefloxacin, pefloxacin, ofloxacin and norfloxacin, which have been approved in > 5000 veterinary product approvals but are also used in human medicine. Production stop is scheduled for Sept. 1, 2015, distribution stop for Dec. 31, 2015. The extensive use of antibiotics was recently publicly critisized in Chinese media reports.

China Bio news release, June 23, 2015